Deepmatter Share Discussion Threads

[mcrudden] 16/10/2020 10:03

If they are panicking now, dread to think what the boiler bunnies will be doing next week lol

[jpuff] 16/10/2020 09:39

A few boiler room shorters panicking now lol ?

[the stigologist] 16/10/2020 09:28

Griffiths dumping like crazy ?

[the stigologist] 16/10/2020 09:27

lol

losers

if you add 5 'customers' to a FREE-mium model then it sounds like you're adding LOSSES

[mcrudden] 16/10/2020 09:07

Spot on, no rush for me, it will return many multiples in time.

[jpuff] 16/10/2020 08:39

I'm very happy and relaxed to hold for the long term, the statement exudes confidence. A perfect penny share to tuck away imo.

[mcrudden] 16/10/2020 08:35

Last line for me, not a day trade lol

[mcrudden] 16/10/2020 08:35

Just the start, Mark Warne, Chief Executive Officer of DeepMatter commented: "We are delighted to be supplying our powerful retrosynthesis and forward planning tools to these leaders in their field, expanding our customer base not only in the Pharmaceutical industry but also within the agrisciences and CRO sectors."With machine learning and cloud technologies both powerful tools in the race to accelerated drug discovery, we see a growing opportunity for both our ICSYNTH and DigitalGlassware(TM) platforms and look to the future with confidence."

[jpuff] 16/10/2020 08:27

This share moves up quickly when it wants to and buying in decent volume can be difficult - an excellent RNS.

[mcrudden] 16/10/2020 08:19

Just the start

[jpuff] 16/10/2020 08:05

Yep, totally agree, onwards and upwards

[mcrudden] 16/10/2020 07:59

Excellent news, I'm enjoy these next few months here in dmtr

[buywell3] 16/10/2020 07:54

No numbers mentioned which buywell thinks is of some concern

[justtrying1] 16/10/2020 07:49

Nice opp for richard griffiths and family to dump a few more percent. Will spike then crash

[jpuff] 16/10/2020 07:29

Further Great news from this gem of a company.....DeepMatter Group PLC Strong adoption of ICSYNTHSource: UK Regulatory (RNS & others)TIDMDMTRRNS Number : 2679CDeepMatter Group PLC16 October 202016 October 2020DeepMatter Group plc("DeepMatter", the "Company" or "the Group")Strong adoption of ICSYNTHDeepMatter doubles customer numbers for its machine-learning retrosynthesis toolDeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, is pleased to announce it has secured contracts with five new major customers over the last two months for its powerful computer aided synthesis design tool, ICSYNTH. In total, ICSYNTH customer numbers have more than doubled through the course of 2020, and the Company has achieved 100% customer renewals, adding to the Group's underlying revenue base. The new customers include some of the world's leading multi-national pharmaceutical, agrisciences, biotech and contract research organisations (CROs). Retrosynthesis is a growing area of the Life Sciences Research & Development space, providing an increasing opportunity for ICSYNTH.ICSYNTH is a powerful computer aided synthesis design tool that enables chemists to generate synthetic pathways for a target molecule, leading to better, faster and more cost-effective synthesis predictions. ICSYNTH facilitates innovation by stimulating ideas for alternative or novel synthetic routes that otherwise may not be considered by the chemist.Development work has recently been completed on a new User Interface for the tool, facilitating greater ease of use, and new algorithms have been introduced to filter out erroneous data from any data source, including proprietary data in Electronic Laboratory Notebooks, leading to improved synthesis predictions resulting in better productivity and time management.Mark Warne, Chief Executive Officer of DeepMatter commented: "We are delighted to be supplying our powerful retrosynthesis and forward planning tools to these leaders in their field, expanding our customer base not only in the Pharmaceutical industry but also within the agrisciences and CRO sectors."With machine learning and cloud technologies both powerful tools in the race to accelerated drug discovery, we see a growing opportunity for both our ICSYNTH and DigitalGlassware(TM) platforms and look to the future with confidence."For more information, please contact: DeepMatter Group plc T: 0141 548 8156 Mark Warne, Chief Executive Officer C anaccord Genuity Limited (Nominated Advisor and Broker) T: 020 7523 8000 Bobbie Hilliam / Angelos Vlatakis Alma PR T: 020 3405 0205 Caroline Forde / Harriet Jackson / Kieran [e-mail] Breheny About DeepMatter Group plcDeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. In the near term this involves the provision of an integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware(TM), to scientists across research and process development sectors.The DigitalGlassware(TM) platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster.Visit: www.deepmatter.io and follow @deepmattergroupThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDCNTMZMMGLKMGGZM(END) Dow Jones NewswiresOctober 16, 2020 02:00 ET (06:00 GMT)

[mcrudden] 16/10/2020 07:11

.... l o l

[mcrudden] 13/10/2020 10:11

Truth hurts doesn't it

[mcrudden] 13/10/2020 10:10

Lol lol lol

[mcrudden] 12/10/2020 23:56

Even Andy munchkin has your card marked.

[jayminpatel1] 12/10/2020 16:02

Whose that pumper on twitter who has failed on this Another tr1 due for the main dumper

[mcrudden] 12/10/2020 15:49

I know absolutely spot on stigologists, I can only dream and wish I had your foresight and investing talent. Maybe, could be, possibly I'd have invested in Ncyt at 24p and still held it today if I had your experience and wisdom. Hindsight hey Lol lol lol

[mcrudden] 12/10/2020 15:42

Thanks I’ll have read, people that think they know everything in reality know nothing 😊

🤖🧪🦠💭8173;💭ԁ73;